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1. Introduction 
Thromboxanes A are a new group of compounds 
with extreme potency to induce platelet aggregation 
and smooth muscle contractions. They are derived 
from prostaglandin endoperoxides and have a half-life 
of only 30-~40 s in aqueous solution (pH 7.4, 37°C). 
Thromboxanes B, the products of the spontaneous 
degradation, are biologically inactive [ 1 ] . Two enzymes 
are required to convert polyunsaturated fatty acids 
to thromboxanes: prostaglandin endoperoxide syn- 
thase (cyclooxygenase) and thromboxane synthase 
(fig.1). These enzymes from human platelets were 
recently solubilized and chromatographically resolved 
[2]. In the present report the ability of various com- 
pounds to inhibit thromboxane synthase from human 
platelets is described. 
2. Materials and methods 
[ 1 -‘4C]Prostaglandin Hz (1 Ci/mol) was prepared 
from [ 1 -14C]arachidonic acid (Radiochemical Centre, 
55 Ci/mol) [3]. The incubation mixture contained 
5 mM L-tryptophan, a cofactor for the conversion of 
prostaglandin Gz to prostaglandin Hz [4]. Phtalazinol 
was kindly provided by Dr T. Shimamoto. 9&l la- 
Azo-15(S)-hydroxy-prosta-S(cis), 13(trans)-dienoic 
acid was a generous gift from Dr E. J. Corey. 9a,l la- 
Epoxymethano-1 S(S)-hydroxy-prosta-S(cis), 13(trans)- 
dienoic acid, 9c~,l la-methanoepoxy-1 S(S)-hydroxy- 
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Fig.1. Enzymes required to convert arachidonic acid to 
thromboxane B,. 
prosta-5(cis), 13(trans)-dienoic acid, prostaglandins 
and thromboxane Bz were kindly provided by the 
Upjohn Company. 5,8,11,14-Eicosatetrayonic acid, 
2-isopropyl-3-nicotinyl-indole and sodium p-benzyl- 
4- [ 1 -oxo-2-(4-chlorobenzyl)-3-phenyl propyl] phenyl 
phosphonate were generously provided by Hoffman 
La Roche, Labaz and Nelson Research, respectively. 
Imidazole was purchased from Sigma. 
2.1. Platelet microsomes 
Washed platelets were prepared from human blood 
collected with 7.5% (v/v) of 77 mM sodium EDTA 
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[3]. The platelets from 400 ml blood were resus- 
pended in 10 mM TrisHCl, pH 7.4 to vol. 10 ml and 
sonicated at 0°C using a Branson sonifier model S-l 25 
(setting no 4); six 5 s treatments separated by 1 min 
intervals for cooling. The fraction sedimenting between 
15OOXgX 15minand100000XgX60minwas 
resuspended in 50 mM Tris buffer, pH 7.4, to vol. 
20 ml. Platelet disruption and subsequent manipula- 
tions were performed at 0--4°C. 
2.2. Enzyme assay 
Resuspended microsomes, 100 ~1, (0.65 mg 
protein/ml) were preincubated with various presumed 
inhibitors at 24°C. After 15 s, 2.5 pg [ 1 -14C] pro- 
staglandin Hz was added and the incubation was con- 
tinued for another 60 s at 24°C. The reaction was 
stopped by adding 0.3 ml diethyl ether/methanol/ 
0.2 M citric acid (30:4:1, v/v/v) precooled to -70°C. 
After rapid mixing and phase separation the lower 
phase was frozen. The ether phase was aspirated. 
mixed with 10 pg unlabeled thromboxane Bz, 
methylated with etheral diazomethane and chromato- 
graphed on silica gel G thin-layer chromatography 
with 2% methanol in diethyl ether as solvent system. 
The thin-layer chromatograms were scanned for 
radioactivity on a Berthold Diinnschichtsscanner 11 
and sprayed with phosphomolybdic acid to detect 
reference compounds. Appropriate zones were then 
scraped off into scintillation vials and counted in a 
Packard Tri Carb 3385 liquid scintillation counter, 
after the addition of 10 ml Permablend@ (4.4 g/l 
toluene/ethanol, 4: 1 v/v) to each vial. Percent con- 
version to thromboxane Ba was obtained by relating 
the radioactivity which co-chromatographed with the 
internal reference thromboxane Bz to the total radio- 
activity recovered from the plate. 
3. Results and discussion 
Radiochromatograms of products from prosta- 
glandin Ha incubations with native and boiled platelet 
microsomes are shown in fig.2. The positions of 
unlabeled thromboxane B2 (A), prostaglandin Ea (B) 
prostaglandin Fza (C) used as internal (A) and exter- 
nal (B and C) reference compounds are also shown. 
The radioactive material co-chromatographing with 
unlabeled thromboxane Ba was analyzed by gas-- 
108 
-1’5 10 
Distance from origin (cm) 
Fig.2. Thin-layer radiochromatogram of products isolated 
after incubations of [ I-“C]prostaglandin H, with native 
flower panel) or boiled human platelet microsomes (upper 
panel). Positions of internal (A) and external (B, C) reference 
compounds are shown with striped areas. (A, thromboxane 
B,; B, prostaglandin E,; C, prostaglandin F,,J. 
liquid chromatography-mass spectrometry and 
identified as thromboxane B2 [2]. 
Recently a number of stable analogues of the 
prostaglandin endoperoxides have been synthesized 
[5-71. Three of these analogues were tested in the 
present investigation. One, 9cr,l la-azo-1 S(S)-hydroxy- 
prosta-5(cis), 13(trans)-dienoic acid (analogue I), was a 
potent inhibitor of thromboxane synthase with an 
IDse of approximately 2 PM. Another relatively 
potent inhibitor was 9a,l la-e;?oxymethano-15(S)- 
hydroxy-prosta S(cis), 13(trans)-dienoic acid (analogue 
II) which gave an IDso 2 X 10m5 M. The thirdanalogue, 
9a,l lar-methanoepoxy-1 S(S)-hydroxy-prosta-5(cis), 
13(trans)-dienoic acid (analogue III) was not effective 
in inhibiting thromboxane synthase (figs. 3-4). The rela- 
tive potency of these compounds as inhibitors of throm- 
boxane synthase parallelled their binding to platelet 
microsomes*, suggesting that the analogues inhibit 
*Diczfalusy, U., Powell, W. S., Hammarstrom, S. and 
Samuelsson, B. unpublished observations 
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Fig.3. Inhibition of thromboxane B, formation from prosta- 
glandin H, as a function of inhibitor concentration. 
thromboxane synthase by binding to the substrate 
site of this enzyme. 
It was recently reported that an anti-inflammatory 
compound, 2-isopropyl-3-nicotinyl-indole (L-8027) 
selectively inhibits thromboxane AZ synthesis [8]. 
This compound was tested in our system and was 
found to be a potent inhibitor (IDso approx. 10 PM, 
fig.3). Benzydamine, which was reported to inhibit 
thromboxane formation by horse platelet microsomes 
[9], was not effective in our system at concentrations 
below 1 mM. It is thus doubtful if this compound 
should be considered a specific inhibitor of throm- 
boxane synthase. It has been reported that imidazole 
is a selective inhibitor of thromboxane formation 
[lo] . Our results (fig.3) confirm that imidazole 
inhibits the conversion of prostaglandin Hz to throm- 
boxane Ba. The potency of imidazole was however 
lo-loo-times less than that of the compounds 
Cwmtr8tion (Ml 
Fig.4. Inhibition of thromboxane B, formation from prosta- 
glandin H, as a function of inhibitor concentration. 
described above (IDS0 1.5 X lo4 M). The acetylenic 
analogue of arachidonic acid 5,8,11,14-eicosate- 
traynoic acid, was not effective in inhibiting throm- 
boxane synthesis (fig.4). Sodium p-benzyl-4- [ l-oxo- 
2-(4-chlorobenzyl)-3-phenyl propyl] phenyl phospho- 
nate (N-0164) has been reported to inhibit the forma- 
tion of thromboxane AZ-like activity from prosta- 
glandin endoperoxides by human platelet microsomes 
[ 111 as assayed on rabbit aorta. The reported ZDse 
(2.4 X lo-’ M) is identical to that obtained in our 
system (fig.4). Phtalazinol (EC-626) did not inhibit 
the conversion of prostaglandin Ha to thromboxane 
Ba catalyzed by human platelet microsomes (fig.4). 
This agrees with a proposal that EG-626 is an antagonist 
of thromboxane action [ 121 rather than an inhibitor 
of thromboxane synthase. 
In conclusion, four compounds were found to be 
good inhibitors of microsomal thromboxane synthase 
from human platelets. These inhibitors (analogue I, 
L8027, analogue II and N-0164, decreasing order of 
potency) had IDso values of 2-24 PM. The endo- 
peroxide analogues I and II have biological activities 
similar to those of prostaglandin Gz and prostaglandin 
Ha [13]. L-8027 and N-0164, however, appear to be 
promising compounds for studies on the relative 
biological importance of prostaglandin endoperoxides 
and thromboxanes in platelets and other tissues. 
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